Metabolic syndrome and chronic kidney disease: Current status and future directions

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

774

WORD

347

HTML

6483

Tables (1-4)

222

Sum=7826

Publishing Process of This Article

Item

Count

Browse

1428

Download

1366

Sum=2794

Nov 6, 2014 (publication date) through Nov 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Nephrol. Nov 6, 2014; 3(4): 210-219
Published online Nov 6, 2014. doi: 10.5527/wjn.v3.i4.210

Table 2 Renal associations of metabolic syndrome

Renal outcome	Ref.
eGFR < 60/mL/min per 1.73 m²	[15,19]
Proteinuria and/or microalbuminuria	[13,22,23,29,30]
Histopathological abnormalities (tubular atrophy, interstitial fibrosis, arterial sclerosis)	[31]
Ultrasound abnormalities (increased intra-renal resistive indices)	[32]

Citation: Prasad GVR. Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol 2014; 3(4): 210-219
URL: https://www.wjgnet.com/2220-6124/full/v3/i4/210.htm
DOI: https://dx.doi.org/10.5527/wjn.v3.i4.210